Platelet expression of PKCepsilon oncoprotein in myelofibrosis is associated with disease severity and thrombotic risk.

scientific article

Platelet expression of PKCepsilon oncoprotein in myelofibrosis is associated with disease severity and thrombotic risk. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.21037/ATM.2017.06.22
P932PMC publication ID5515809
P698PubMed publication ID28758099

P50authorFranco AversaQ45309228
Elena MasselliQ56126120
P2093author name stringMarco Vitale
Silvia Martini
Prisco Mirandola
Cecilia Carubbi
Daniela Galli
Giuliana Gobbi
Giulia Pozzi
P2860cites workPhorbol ester-induced PKCepsilon down-modulation sensitizes AML cells to TRAIL-induced apoptosis and cell differentiationQ46260995
Timing and expression level of protein kinase C epsilon regulate the megakaryocytic differentiation of human CD34 cells.Q50897596
Dynamic International Prognostic Scoring System (DIPSS) predicts progression to acute myeloid leukemia in primary myelofibrosis.Q53166045
Thrombosis in primary myelofibrosis: incidence and risk factorsQ61050096
Markers of platelet activation and platelet-leukocyte interaction in patients with myeloproliferative syndromesQ73012008
Increased soluble and platelet-associated CD40 ligand in essential thrombocythemia and reactive thrombocytosisQ77768132
Dual role of platelet protein kinase C in thrombus formation: stimulation of pro-aggregatory and suppression of procoagulant activity in plateletsQ79517819
New prognostic scoring system for primary myelofibrosis based on a study of the International Working Group for Myelofibrosis Research and TreatmentQ79802927
Risk stratification of patients with acute myocardial infarction by quantification of circulating monocyte-platelet aggregatesQ79838195
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemiaQ27853375
Leukocyte-platelet interaction in patients with essential thrombocythemia and polycythemia veraQ28174281
Differential roles of the PKC novel isoforms, PKCdelta and PKCepsilon, in mouse and human plateletsQ33386819
Protein kinase C ε expression in platelets from patients with acute myocardial infarctionQ34447109
Mechanisms of thrombus formationQ34815800
Platelet receptors and signaling in the dynamics of thrombus formation.Q37175605
Myeloproliferative neoplasms: contemporary diagnosis using histology and geneticsQ37608910
Protein kinase Cε as a cancer marker and target for anticancer therapyQ37858343
Arterial thrombus formation in cardiovascular diseaseQ37897474
Protein kinase C ε in hematopoiesis: conductor or selector?Q38069796
Myeloproliferative neoplasms and thrombosis.Q38119076
Cytofluorimetric platelet analysis.Q38175007
Hypoxia-induced down-modulation of PKCepsilon promotes trail-mediated apoptosis of tumor cells.Q39674856
Human thrombopoiesis depends on Protein kinase Cδ/protein kinase Cε functional coupleQ39849058
Regulation of outside-in signaling in platelets by integrin-associated protein kinase C betaQ40493902
Protein kinase Cɛ inhibition restores megakaryocytic differentiation of hematopoietic progenitors from primary myelofibrosis patientsQ40727272
Assessment of platelet activation in myeloproliferative disorders with complementary techniquesQ44827234
P4510describes a project that usesImageJQ1659584
P433issue13
P921main subjectmyelofibrosisQ1752571
P304page(s)273
P577publication date2017-07-01
P1433published inAnnals of Translational MedicineQ26842362
P1476titlePlatelet expression of PKCepsilon oncoprotein in myelofibrosis is associated with disease severity and thrombotic risk
P478volume5

Reverse relations

cites work (P2860)
Q38649543Cancer diagnostics: current concepts and future perspectives
Q61796079Combination of Platelet expression of PKCepsilon and cardiac troponin-I for early diagnosis of chest pain patients in the emergency department
Q88138812The -2518 A/G polymorphism of the monocyte chemoattractant protein-1 as a candidate genetic predisposition factor for secondary myelofibrosis and biomarker of disease severity

Search more.